Royalty Pharma (RPRX) Change in Acquisitions & Divestments: 2019-2025
Historic Change in Acquisitions & Divestments for Royalty Pharma (RPRX) over the last 5 years, with Sep 2025 value amounting to $2.9 million.
- Royalty Pharma's Change in Acquisitions & Divestments changed negligibly% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.9 million, marking a year-over-year decrease of 2.09%. This contributed to the annual value of $19.8 million for FY2024, which is 18.88% down from last year.
- Per Royalty Pharma's latest filing, its Change in Acquisitions & Divestments stood at $2.9 million for Q3 2025, which was down 0.00% from $2.9 million recorded in Q2 2025.
- In the past 5 years, Royalty Pharma's Change in Acquisitions & Divestments registered a high of $624.4 million during Q3 2021, and its lowest value of $1.4 million during Q1 2024.
- Moreover, its 3-year median value for Change in Acquisitions & Divestments was $2.9 million (2025), whereas its average is $7.8 million.
- Per our database at Business Quant, Royalty Pharma's Change in Acquisitions & Divestments crashed by 94.10% in 2024 and then soared by 774.03% in 2025.
- Over the past 5 years, Royalty Pharma's Change in Acquisitions & Divestments (Quarterly) stood at $104.7 million in 2021, then increased by 10.43% to $115.6 million in 2022, then tumbled by 91.12% to $24.4 million in 2023, then tumbled by 94.10% to $12.6 million in 2024, then remained steady at $2.9 million in 2025.
- Its Change in Acquisitions & Divestments was $2.9 million in Q3 2025, compared to $2.9 million in Q2 2025 and $12.6 million in Q1 2025.